CTI, Humanigen Inc. dose first COVID-19 patient with FDA-approved lenzilumab proprietary antibody
Covington’s CTI partner, Humanigen Inc., has announced that the first COVID-19 patient has been dosed with its FDA-approved proprietary antibody…
Tm Schroder
Read More